Literature DB >> 25205450

Natural course of hypogonadism diagnosed during hospitalization in aged male patients.

P Iglesias1, F Prado, A Muñoz, M T Guerrero, M C Macías, E Ridruejo, P Tajada, C García-Arévalo, J J Díez.   

Abstract

Our aim was to assess short-term natural course of hypogonadism diagnosed during hospitalization for acute disease in aged male patients after discharge. A group of 43 hypogonadal males, aged 86.7±5.7 year, was studied. Serum concentrations of testosterone (T) and gonadotropins (follicle-stimulating hormone, FSH, and luteinizing hormone, LH) were measured in every patient both at admission and one month after discharge. Mean serum T at entry was 115.4±48.0 ng/dl. Hypogonadism was hyper-, hypo-, and normogonadotropic in 20 (46.5%), 20 (46.5%), and 3 (7.0%) patients, respectively. One month after discharge serum T concentrations increased significantly (230.9±135.6 ng/dl, p<0.001). At this point, more than half of the patients (n=27, 62.8%) showed normal serum T concentrations. Both gonadotropins, FSH (p<0.001), and LH (p=0.04) also increased one month after discharge. Approximately, half of the patients (13, 48.1%) who normalized serum T concentrations also showed normal serum gonadotropin concentrations. Patients who normalized their serum T concentrations one month after discharge showed significantly higher baseline values of T (134.7±33.9 ng/dl) than those who persisted with hypogonadism (n=16, 32.7%; 82.8±51.6 ng/dl, p<0.001). Lastly, serum T was the only independent predictor for achieving eugonadal status (OR 1.030; CI 95%, 1.010-1.050; p<0.001). In conclusion, about 63% of aged patients hospitalized for acute illness with hypogonadism discovered during hospitalization spontaneously normalize their serum T concentrations one month after discharge. Serum gonadotropin concentrations also increased after discharge. Serum T levels at admission was an independent predictor for the normalization of serum T concentrations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25205450     DOI: 10.1007/s12020-014-0417-5

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  28 in total

Review 1.  Age-related changes in testosterone and the role of replacement therapy in older men.

Authors:  Carolyn A Allan; Robert I McLachlan
Journal:  Clin Endocrinol (Oxf)       Date:  2004-06       Impact factor: 3.478

Review 2.  Testosterone and heart failure.

Authors:  Maurizio Volterrani; Giuseppe Rosano; Ferdinando Iellamo
Journal:  Endocrine       Date:  2012-06-24       Impact factor: 3.633

3.  Serum testosterone but not leptin predicts mortality in elderly men.

Authors:  Aapo Lehtonen; Risto Huupponen; Jaakko Tuomilehto; Sirkku Lavonius; Seija Arve; Hannu Isoaho; Ilpo Huhtaniemi; Reijo Tilvis
Journal:  Age Ageing       Date:  2008-03-12       Impact factor: 10.668

4.  Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.

Authors:  S M Harman; E J Metter; J D Tobin; J Pearson; M R Blackman
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

5.  Diagnosis of hypogonadism in the aging male.

Authors:  A Vermeulen; J M Kaufman
Journal:  Aging Male       Date:  2002-09       Impact factor: 5.892

6.  The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men.

Authors:  Thomas G Travison; Andre B Araujo; Varant Kupelian; Amy B O'Donnell; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2006-12-05       Impact factor: 5.958

Review 7.  Androgens and cardiovascular disease.

Authors:  Bu B Yeap
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-06       Impact factor: 3.243

8.  Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe Casanueva; Gianni Forti; Aleksander Giwercman; Ilpo T Huhtaniemi; Krzysztof Kula; Margus Punab; Steven Boonen; Dirk Vanderschueren
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

9.  Prevalence of symptomatic androgen deficiency in men.

Authors:  Andre B Araujo; Gretchen R Esche; Varant Kupelian; Amy B O'Donnell; Thomas G Travison; Rachel E Williams; Richard V Clark; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2007-08-14       Impact factor: 5.958

10.  Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.

Authors:  C Wang; E Nieschlag; R Swerdloff; H M Behre; W J Hellstrom; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; A Morales; J E Morley; C Schulman; I M Thompson; W Weidner; F C W Wu
Journal:  Eur J Endocrinol       Date:  2008-11       Impact factor: 6.664

View more
  1 in total

1.  Androgen receptor GGC repeat might be more involved than CAG repeat in the regulation of the metabolic profile in men.

Authors:  Giacomo Tirabassi; Melissa Cutini; Benedetta Beltrami; Nicola Delli Muti; Andrea Lenzi; Giancarlo Balercia
Journal:  Intern Emerg Med       Date:  2016-06-01       Impact factor: 3.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.